title: Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countries. The ARISE project.
abstract: Over a 7-month period in 2000-2001, 1213 Haemophilus influenzae, 112 Haemophilus parainfluenzae and 142 Moraxella catarrhalis isolates were recovered from adult patients with respiratory tract infections. Patients were from four southern European countries (Spain, Italy, Portugal and Greece). The antimicrobial susceptibility of the isolates to 11 antibiotics was determined in a central laboratory. The most active drugs on the basis of MICs were levofloxacin, cefditoren, cefotaxime, cefpodoxime and amoxicillin/clavulanate. MICs > or = 2 mg/l for amoxicillin were found in 19.5, 28.6, and 75.4% of H. influenzae, H. parainfluenzae and M. catarrhalis isolates, respectively. Isolates of H. influenzae and H. parainfluenzae with reduced susceptibility or that were fully resistant to amoxicillin/clavulanate, cefuroxime and clarithromycin were detected (0.2-1.8%) as well as M. catarrhalis resistant to clarithromycin (0.7%). Regular surveys of resistance patterns for antimicrobial agents are necessary.
authors.affiliation: Department of Medical Microbiology, Avenida de Reyes Católicos 2, 28040 Madrid, Spain. fsoriano@fjd.es
authors.forename: F
authors.initials: F
authors.lastname: Soriano
authors.forename: J J
authors.initials: JJ
authors.lastname: Granizo
authors.forename: P
authors.initials: P
authors.lastname: Coronel
authors.forename: M
authors.initials: M
authors.lastname: Gimeno
authors.forename: E
authors.initials: E
authors.lastname: Ródenas
authors.forename: M
authors.initials: M
authors.lastname: Gracia
authors.forename: C
authors.initials: C
authors.lastname: García
authors.forename: R
authors.initials: R
authors.lastname: Fernández-Roblas
authors.forename: J
authors.initials: J
authors.lastname: Esteban
authors.forename: I
authors.initials: I
authors.lastname: Gadea
mesh_terms: D000328:Adult; D000658:Amoxicillin / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D024901:Drug Resistance, Multiple, Bacterial; D006115:Greece; D006192:Haemophilus Infections / Q000188:drug therapy / Q000382:microbiology*; D006193:Haemophilus influenzae / Q000187:drug effects* / Q000302:isolation & purification*; D044135:Haemophilus parainfluenzae / Q000187:drug effects* / Q000302:isolation & purification*; D006801:Humans; D007558:Italy; D008826:Microbial Sensitivity Tests; D001936:Moraxella catarrhalis / Q000187:drug effects* / Q000302:isolation & purification*; D045828:Moraxellaceae Infections / Q000188:drug therapy / Q000382:microbiology*; D011174:Portugal; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000382:microbiology*; D013030:Spain
chemical_list: D000658:Amoxicillin